Adidas Warns of Price Hikes Amid Trump Tariffs, Stock Plunges
Adidas Warns of Price Hikes Amid Trump Tariffs, Stock Plunges
Gold on the Brink of a Major Rally: Key Drivers in Focus
Tönnies Parent Company Aims to Acquire Germany’s Second-Largest Sausage Producer
Canada Nickel Co. Focuses on Expanding Nickel-Cobalt Exploration in Ontario
Stocks Edge Higher, Dollar Slips as Trade Tensions Weigh on Markets
DatChat Inc. Expands Its Reach in Secure Messaging Technology
Tesla Faces Setback in China as Sales Decline Amid Fierce Competition
Autonomix Medical: Pioneering Neural Signal Technology in Medical Devices
Volkswagen Ramps Up Production at Wolfsburg Plant Amid High Demand for Combustion Models
SciSparc Ltd. (NASDAQ: SPRC) is an early-stage biopharmaceutical company developing cannabinoid-based therapies for central nervous system disorders. For investors seeking exposure to innovative healthcare solutions,
Aedas Homes has closed its 2024–2025 fiscal year, ending in March, with a record-breaking commercial performance. The Spanish developer secured 3,275 build-to-sell pre-sales to individual
Shares of OHLA, a Spanish construction company, experienced sharp declines of nearly 10% on the stock market after news broke that it must pay guarantees
PaxMedica, Inc., a clinical-stage biopharmaceutical company based in Tarrytown, New York, is focused on developing innovative treatments for several challenging neurological conditions. Founded in 2018
Lufthansa Group is expanding its business by entering the package travel market. The airline conglomerate has established Eurowings Holidays GmbH, a new tour operator dedicated
REE Automotive Ltd. is at the forefront of automotive technology, developing cutting-edge platforms that serve as the foundation for the next generation of zero-emission vehicles.
The annual energy cost analysis for German households reveals a significant financial burden. With electricity prices showing a slight decrease in 2024, gas costs surged.
OneMedNet Corp., a leading innovator in clinical imaging technology, is making significant strides in transforming the healthcare industry. The company specializes in developing advanced tools
Bitcoin’s meteoric rise has brought it tantalizingly close to the $100,000 mark. But what comes next? Should you jump in, hold on, or cash out?
Immunome, Inc., a trailblazing biopharmaceutical company, is dedicated to advancing the frontiers of antibody therapeutics. Founded on March 2, 2006, by Scott K. Dessain and
